An animated image that portrays a critical and urgent moment in the treatment of sepsis, focusing on a female doctor in a standard hospital room handling an IV.

IV Fluid Management in Sepsis

An animated image that portrays a critical and urgent moment in the treatment of sepsis, focusing on a female doctor in a standard hospital room handling an IV.

IV Fluid Management in Sepsis

In the treatment of sepsis, intravenous (IV) fluid management is a critical aspect of hemodynamic resuscitation aimed at restoring fluid volume and enhancing tissue perfusion. The administration of fluids in sepsis requires a delicate balance as excessive fluid can lead to complications such as edema and organ dysfunction. Recent research highlights the importance of using balanced crystalloids over saline and initiating resuscitation with smaller fluid volumes to mitigate potential harm.

Optimal Fluid Administration and Vasopressors

The systemic inflammation observed in sepsis often leads to increased vascular permeability and vasodilation, resulting in a marked reduction in intravascular volume. This can precipitate hypotension, significantly reducing organ perfusion. Administering IV fluids is essential to restore circulatory volume, ensuring organs receive the necessary blood supply for optimal function. Rapid infusion of IV fluids at a rate of 30 mL per kg of actual body weight within the first 3 hours is recommended for resuscitation purposes, except in patients with pulmonary edema. Research indicates that mortality outcomes do not significantly differ between using 2-3 liters versus 3-5 liters of resuscitation fluid. Fluid administration should be in 500 mL boluses until a hemodynamic response is achieved, typically up to 2-3 liters. In cases where the patient is at risk for pulmonary edema or perfusion does not improve, early use of vasopressors after 2 liters of fluid has been administered shows no mortality benefit compared to continued fluid administration beyond this point (PMID: 24635773, 25272316, 25776532, 36688507).

Early Goal-Directed Therapy (EGDT) Protocols

In the context of Early Goal-Directed Therapy (EGDT) protocols aimed at managing critically ill patients, such as those with sepsis, specific targets are established to ensure effective treatment outcomes. These include maintaining central venous oxygen saturation (ScvO2) at or above 70%, keeping central venous pressure (CVP) within the range of 8-12 mmHg, ensuring mean arterial pressure (MAP) remains at or above 65mmHg, and achieving a urine output of at least 0.5 mL/kg/hr. These parameters are crucial for monitoring and fine-tuning therapeutic interventions to promote adequate tissue perfusion and organ function, thereby optimizing patient recovery and survival rates (PMID:  31454263, 35407578, 29485925).

The Debate Over Fluid Choices

Recent investigations, including studies from the medical ICU (ClinicalTrials.gov NCT02444988) and comprehensive meta-analyses (PubMed IDs 31454263, 35407578), have highlighted the potential advantages of balanced crystalloids over saline. Balanced crystalloids may offer lower in-hospital mortality rates and a reduced incidence of major adverse kidney events, underscoring the significance of informed fluid choice in improving sepsis outcomes (PMID: 35801708). Balanced crystalloids are also considered the preferred fluid for sepsis resuscitation due to their availability and cost-effectiveness, with 0.9% saline linked to more kidney dysfunction and higher mortality rates (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851923/). 

The selection of IV fluids—whether albumin, crystalloid solutions, or others like pentastarch and hydroxyethyl starch—has been extensively debated. Current evidence suggests no significant difference in outcomes between albumin and crystalloid solutions for sepsis treatment (PMID: 24635772, 25499187, 25474401). However, starch solutions have been associated with potential harm, and hypertonic saline has not demonstrated a beneficial role in sepsis management (PMID: 22738085, 18184958, 28219612). Conversely, balanced salt solutions may present a superior alternative to normal saline, likely due to their reduced risk of causing hyperchloremic acidosis.


In conclusion, selecting the appropriate IV fluids for sepsis management is crucial. IV fluid management in sepsis is a complex, critical aspect of patient care, requiring a nuanced understanding of the condition’s pathophysiology and the effects of various fluid therapies. Balanced crystalloids are favored over saline due to their availability, cost-effectiveness, and potential benefits in improving patient-centered outcomes. Avoiding hydroxyethyl starch solutions is essential due to their associated risks. By adhering to EGDT protocols and considering the latest evidence on fluid choices, healthcare professionals can optimize treatment strategies, ultimately improving outcomes for patients with sepsis.

Learn more About How we help clinicians improve patient outcomes

Schedule a call with our team to discuss how we are helping our clients revolutionize how clinicians manage patient interventions.